BIOLASE Inc (BIOL.OQ)

BIOL.OQ on NASDAQ Stock Exchange Capital Market

2.69USD
4:00pm EDT
Price Change (% chg)

$-0.03 (-1.10%)
Prev Close
$2.72
Open
$2.72
Day's High
$2.73
Day's Low
$2.65
Volume
30,388
Avg. Vol
86,470
52-wk High
$3.52
52-wk Low
$1.47

BIOL.OQ

Chart for BIOL.OQ

About

BIOLASE, Inc., formerly BIOLASE Technology, Inc. is a medical technology company that develops, manufactures and markets lasers, and markets and distributes dental imaging equipment and other related products designed for applications and procedures in dentistry and medicine. The Company's dental laser systems allow dentists,... (more)

Overall

Beta: 2.57
Market Cap (Mil.): $119.37
Shares Outstanding (Mil.): 43.89
Dividend: --
Yield (%): --

Financials

  BIOL.OQ Industry Sector
P/E (TTM): -- 42.46 33.29
EPS (TTM): -0.50 -- --
ROI: -279.77 6.83 17.33
ROE: -318.17 10.97 18.19
Search Stocks

Auxilium Pharma backs QLT deal, adopts poison pill after Endo's bid

- Auxilium Pharmaceuticals Inc said it would not withdraw its offer to buy Canadian eye drug maker QLT Inc and adopted a poison pill, a day after receiving an unsolicited buyout offer from Endo International Plc.

8:19am EDT

Auxilium Pharma adopts poison pill after Endo's unsolicited bid

Sept 17 - Auxilium Pharmaceuticals Inc adopted a poison pill with a 15 percent trigger, a day after an unsolicited $2.2 billion buyout offer from Endo International Plc .

7:23am EDT

UPDATE 2-Endo's $2.2 bln offer could complicate Auxilium Pharma's QLT deal

Sept 16 - Endo International Plc made an unsolicited offer to buy Auxilium Pharmaceuticals Inc for about $2.2 billion, which analysts said could complicate Auxilium's buyout of Canadian eye drug maker QLT Inc .

16 Sep 2014

Endo offers to buy Auxilium Pharma for about $2.2 billion

- Specialty healthcare company Endo International Plc offered to buy Auxilium Pharmaceuticals Inc for about $2.2 billion in cash and stock to expand its men's healthcare products business.

16 Sep 2014

UPDATE 1-Endo offers to buy Auxilium Pharma for about $2.2 bln

Sept 16 - Specialty healthcare company Endo International Plc offered to buy Auxilium Pharmaceuticals Inc for about $2.2 billion in cash and stock to expand its men's healthcare products business.

16 Sep 2014

Endo offers to buy Auxilium Pharma for about $2.2 bln

Sept 16 - Endo International Plc offered to acquire Auxilium Pharmaceuticals Inc for about $2.2 billion in cash and stock.

16 Sep 2014

UPDATE 1-Endo raises forecast, reports better-than-expected profit

July 31 - Specialty healthcare company Endo International Plc reported a better-than-expected quarterly profit, helped by a 60 percent surge in U.S. generic sales, and raised its full-year forecast for the second time this year.

31 Jul 2014

Endo tops Wall Street quarterly estimates

- Specialty healthcare company Endo International Plc reported a better-than-expected quarterly profit, helped by a 60 percent rise in U.S. generic sales, and it raised its full-year forecast.

31 Jul 2014

Endo tops Wall Street quarterly estimates

July 31 - Specialty healthcare company Endo International Plc reported a better-than-expected quarterly profit, helped by a 60 percent rise in U.S. generic sales, and it raised its full-year forecast.

31 Jul 2014

UPDATE 1-Breakaway bull gores three men in closing Pamplona run

(Updates number of gored runners, adds details on nationalities)

14 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Reuters Investment Profile
$20.00
Provider: Jefferson Research
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks